Wainberg ZA, Melisi D, Macarulla T, Pazo Cid R, et al. NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial. Lancet 2023 Sep 11:S0140-6736(23)01366-1. doi: 10.1016/S0140-6736(23)01366.
PMID: 37708904